Paradigm Diagnostics' Series B - II Round

Paradigm Diagnostics raised a round of funding on February 16, 2017. Investors include New Science Ventures.

Paradigm Diagnostics is a molecular information corporation established to bring comprehensive and clinically actionable cancer genomic profiling to physicians and patients. Paradigm's Next-Generation…

Articles about Paradigm Diagnostics' Series B - II Round: